Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × enzalutamide × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 22 Prostatic Neoplasms, Castration-Resistant 4 Recurrence 2 Neoplasm Metastasis 2 Metastatic Castration-Resistant Prostate Cancer 2 mCRPC 1 Small Cell Lung Carcinoma 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Primary Dysautonomias 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm, Residual 1 Metastatic Hormone-sensitive Prostate Cancer 1 Lymphoma, Follicular 1 Kidney Diseases 1 Hypertension 1 Dementia 1 Cognitive Dysfunction 1 Breast Neoplasms 1 Bites and Stings 1 Biochemically Recurrent Prostate Cancer 1

Interventions

durvalumab 3 Fulvestrant 3 Carboplatin 3 pembrolizumab 2 Pemetrexed 2 Cisplatin 2 trametinib 1 ribociclib 1 pralsetinib 1 palbociclib 1 exemestane 1 darolutamide 1 dabrafenib 1 ceralasertib 1 STX-478 1 Radiosurgery 1 Paclitaxel 1 Letrozole 1 Immunotherapy 1 Gemcitabine 1 Cetuximab 1 Anastrozole 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡